Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-3

(Form Type)

 

Checkpoint Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

   Security
Type		  Security
Class Title		  Fee
Calculation
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Unit		   Proposed Maximum
Aggregate
Offering
Price		   Fee Rate   Amount of
Registration
Fee		 
Fees to be paid  Equity  Common Stock, par value $0.0001 per share   457(c)   13,030,229(1)  $1.78(2)  $ 23,193,807.62   $0.00014760   $3,423.41 
      Total Offering Amounts             $23,193,807.62        $3,423.41 
      Total Fee Offsets              --         -- 
      Net Fee Due             $23,193,807.62        $3,423.41 

 

(1) Consists of an aggregate of 13,030,229 shares of common stock registered for sale by certain of the selling stockholders named in this registration statement consisting of: 6,325,354 shares of common stock, $0.0001 par value, underlying those certain Series A warrants, 6,325,354 shares of common stock, $0.0001 par value, underlying those certain Series B warrants, and 379,521 shares of common stock, $0.0001 par value, underlying those certain Placement Agent Warrants.
   
(2) Determined pursuant to Rule 457(c) and 457(h) under the Securities Act of 1933, as amended (the “Securities Act”), solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Company’s common stock (“Common Stock”) on the Nasdaq Capital Market on November 13, 2023.

 

Table 2: Fee Offset Claims and Sources

N/A

 

Table 3: Combined Prospectuses

N/A